findmyKOL

Nathan Thielman, MD

Enriched profile

Professor of Medicine and Global Health; Director, Global Health Pathway for Residents and Fellows · Duke University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Durham, NC · Southeast · United StatesSpecialtyInfectious DiseaseFocusHIV/AIDS Research and Interventions+4
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2022–2022NIH funding2012–2026

Nathan Thielman is Professor of Medicine and Global Health; Director, Global Health Pathway for Residents and Fellows at Duke University School of Medicine. OpenAlex indexes 266 publications with 8,366 citations (h-index 47); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 10 Oct 2026

Overview

Updated 14 Oct 2026

Nathan Thielman, MD, is Professor of Medicine and Global Health at Duke University School of Medicine. The public record shows 266 publications with 8,366 citations (h-index 47), centered on HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk, HIV-related health complications and treatments. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 1 companies, 5 NIH-funded awards (2012–2026).

  • Most recent indexed publication: 2025 · The Journal of infectious diseases
  • Top research focus: HIV/AIDS Research and Interventions
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV2 trialsTuberculosis1 trialSepsis / Serious Bacterial1 trialShock, Septic1 trialShock1 trial

Research focus

OpenAlex concept fingerprint
HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV-related health complications and treatmentsHIV/AIDS Impact and ResponsesPoverty, Education, and Child Welfare

Drugs & molecules

across trials, industry payments and publications
CabenuvaClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Duke UniversityClinical trials3Industry payments—University of South CarolinaClinical trials1Industry payments—ViiV Healthcare CompanyClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
266publications

Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.

8,366citations

Total citations across indexed works.

47h-index

Hirsch index (OpenAlex). i10-index 132.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2022–2022

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 2012–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

1 company reported payments to CMS in program years 2022–2022. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    84%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor46.2%
    Dovato45%Tivicay31%Juluca17%Isentress8%
    Part D<11 patients
    Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor12.6%
    Pifeltro61%Etravirine26%Efavirenz-Emtric-Tenofov Disop14%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    11.9%
    Statin9.5%
    Atorvastatin Calcium84%Livalo16%
    Part D<11 patients
    Calcium channel blocker2.4%
    Amlodipine Besylate100%
    Part D<11 patients
  • Respiratory

    2.4%
    Corticosteroid2.4%
    Fluticasone Propionate100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

5 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:

Congress activity

Updated 14 Oct 2026

1 congress contribution (2018) across ASH per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jan Ostermann79Brian Wells Pence68Kathryn Whetten56Julian Thornton Hertz37Francis Musa Sakita32Rachel Whetten29Dafrosa Itemba28John A. Crump23Michael J. Mugavero23Gerald S. Bloomfield23John A Bartlett22Jane Leserman18Amy M. Hobbie18Preeti Manavalan18Amy Durr Heine18Bradley Neil Gaynes18Blandina Theophil Mmbaga18Godfrey L. Kweka17Elizabeth Asiago Reddy16Bernard Njau16Richard L. Guerrant16Venance P. Maro15John F. Shao15Evelyn Byrd Quinlivan14Melissa H. Watt14Deng B. Madut13James Luther Raper13Janet Prvu Bettger13Tumsifu G. Tarimo13Jerome J. Mlangi12Karen O’Donnell12Susan Reif12Lynne C. Messer12Coleen K. Cunningham11Peter S. Kussin11Elizabeth Louise Turner11Gloria August Temu11Joseph R. Egger10Marvin S. Swartz10Dalene K. Stangl10

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/nathan-thielman-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalhealth.duke.edu ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalhealth.duke.edu ↗

Editorial & leadership roles

journal and society appointments
  • Past member

    Advisory Council, National Institute of Allergy and Infectious Diseases

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalhealth.duke.edu ↗
  • Member

    CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globalhealth.duke.edu ↗

Awards & honors

honors on the public record
  • Leonard Palumbo

    Jr., MD, Faculty Achievement Award, Duke University School of Medicine

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
  • Excellence in Mentoring

    Duke Global Health Institute

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.